Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Broad based buying seen in markets
Mon, 20 Oct 11:30 am

After opening positive, the Indian Indices have continued to gain momentum during the morning trading session. Apart from IT stocks, broad based buying interest is prevalent in the markets. Banking and engineering stocks are leading the gainers.

The Sensex today is trading up 402 points. The NSE-Nifty is trading up 125 points. The BSE Mid Cap index is trading up 1.5% and the BSE Small Cap index is trading up 1.4%%. The rupee is trading at 61.27 to the US dollar.

Majority of the Indian pharma stocks are trading firm with Dishman pharma and JB chemicals being the leading gainers. A financially daily reports that the salaries of Ranbaxy Ltd will be getting pay cut shield post the acquisition by Sun pharma. It is important to note that the salaries of both the companies differ quite significantly. The salaries of Ranbaxy are on higher end. Salaries in Sun and Ranbaxy differ by 20-30%. Reportedly, the agreement agreed to by Sun pharma for a buyout of Ranbaxy from its parent company Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered. Further, Ranbaxy is said to have also budgeted around Rs 650 m for a retention bonus and identified 70-75 executives to distribute this. Thus Sun pharma may not be able to lower the salaries at least till Dec 2015. However, concerns related to inconsistency in the long term continue to prevail.

All the telecom stocks are trading in the green today. Idea Cellular and Tata Communications are leading the gainers. As per a leading financial daily, the Bharti Airtel-Loop deal is witnessing some progress but it is still far from going through. Loop has sought time till 31 October to comply with the regulator TRAI's direction to inform its customers about the end of its services. The company has sought this extension as the Department of Telecom (DoT) has not yet approved the deal. The company's license will expire on 29 November and has not renewed it. The Dot estimates that Loop owes the government about Rs 8 bn and has thus held up the deal. Both Bharti and Loop have appealed to the DoT to approve the deal quickly as the end user would be at the receiving end of this logjam.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Broad based buying seen in markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.